Table 1.
Demographic and clinical characteristics for HIV-infected men at enrollment visit, Session 1 (n=45).
| Variables | M (SD) or n (%) | Median (IQR) | Range |
|---|---|---|---|
|
Socio-demographic factors
| |||
| Age | 32.36 (8.77) | 30 (18) | 18–45 |
| Education | |||
| <High school | 23 (51) | ||
| High school graduate | 12 (27) | ||
| >High school | 10 (22) | ||
| Race/Ethnicity | |||
| Black, not Hispanic | 42 (93) | ||
| White, not Hispanic | - | ||
| Other | 3 (7) | ||
| Unemployed | 32 (71) | ||
| Sexual identity | |||
| Only straight/heterosexual | 7 (15) | ||
| Mostly straight/heterosexual | 3 (7) | ||
| Only gay | 22 (49) | ||
| Mostly gay | 4 (9) | ||
| Bisexual | 9 (20) | ||
|
| |||
| Risky health behaviors | |||
|
| |||
| Smoking | |||
| Never | 9 (20) | ||
| Former | 4 (9) | ||
| Current | 32 (71) | ||
| Number of Alcohol drinks/week | 1.31 (1.71) | 1 (1.5) | 0–9 |
| Current use | |||
| Marijuana | 27 (60) | ||
| Number of times used/week | 3.26 (4.78) | 2 (3) | 0–25 |
| Urine toxicology screen positive for marijuana | 22 (49) | ||
| Cocaine | 1 (2) | ||
| Heroin | 0 (0) | ||
| Methadone | 0 (0) | ||
| Methamphetamines | 1 (2) | ||
| Ever dependent/abuse alcohol | 11 (24) | ||
| Ever dependent/abuse substances | 15 (33) | ||
|
| |||
| Psychological profile | |||
|
| |||
| Major depression† in lifetime but not past year | 15 (33) | ||
| Depressive symptoms (CES-D)(range: 0–60) | 11.67 (7.09) | 10 (11) | 1–28 |
| Perceived stress (PSS-10)(range: 0–40) | 19.38 (5.44) | 20 (5) | 2–39 |
| PTSD symptoms (PCL-C)(range: 17–85) | 25.91 (7.85) | 23 (9) | 17–46 |
| Childhood Trauma (CTQ) | |||
| Emotional abuse (range: 5–25) | 9.50 (4.98) | 7 (7) | 5–24 |
| Physical abuse (range: 5–25) | 9.18 (4.89) | 7 (4) | 5–25 |
| Sexual abuse (range: 5–25) | 8.93 (6.01) | 5 (7) | 5–25 |
| Emotional neglect (range: 5–25) | 11.31 (5.16) | 10 (8) | 5–21 |
| Physical neglect (range: 5–25) | 8.64 (3.83) | 8 (6) | 5–21 |
| Negative Life events (SLE)(range: 0–54) | 7.93 (5.87) | 6 (7) | 1–28 |
| Reported exposure to interpersonal violenceǂ | 14 (31) | ||
| Reported exposure to sexual abuseǂ | 10 (22) | ||
|
| |||
| Clinical characteristics | |||
|
| |||
| Body mass index | 23.33 (4.39) | 23 (5.5) | 15.97–38.13 |
| Years living with HIV | 8.17 (6.30) | 6 (12) | 0.40–24.18 |
| Medication adherence (MASRI) missing ≥1 dose: | |||
| 3 days summated before visit | 13 (29) | ||
| 2 weeks before visit | 16 (35) | ||
| Last month± | 20 (44) | ||
| CD4 Count (cells/μl) | |||
| > 500 | 25 (56) | ||
| ≥ 200 and ≤ 500 | 14 (31) | ||
| < 200 | 6 (13) | ||
| Viral Load (HIV RNA (cp/ml)) | |||
| Undetectable | 18 (43) | ||
| Lowest detectable limit (20 cp/ml) | 10 (24) | ||
| < 10,000 | 10 (24) | ||
| ≥ 10,000 | 4 (9) | ||
Note. IQR=Interquartile Range. Current use=use in the last month. CES-D= Center for Epidemiologic Studies Depression Scale; PSS-10=Perceived Stress Scale; PCL-C=PTSD Checklist-Civilian Version; CTQ=Childhood Trauma Questionnaire; SLE=Schedule of Negative Life Events Checklist; PSQI=Pittsburgh Sleep Quality Index; MASRI= Medication Adherence Self-Report Inventory; sexual identity scale based on 57.
†
based on the Structural Clinical Interview of Mental Health Disorders (SCID);
±
visual analogue scale for proportion of doses taken in the last month;
ǂ
based on information extracted from the PTSD module on the SCID.